The procedure for conducting a preclinical study of medicinal products, requirements for conditions of the separate studies, as well as the procedure for expert evaluation of materials for preclinical study of medicinal products shall be established by the central executive authority in charge of shaping the state policy in the field of healthcare with due regard to internationally accepted norms.